Clinical Trial: Drug-Coated Balloon Only Strategy After Recanalization of Chronic Total Coronary Occlusions

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817719) titled 'Drug-Coated Balloon Only Strategy After Recanalization of Chronic Total Coronary Occlusions' on Sept. 01.

Brief Summary: Chronic total occlusions (CTO) of the coronary arteries are usually treated with drug-eluting stents (DES) after successful recanalization. Permanent metallic scaffolds carry recognized long-term limitations, including late malapposition, very late stent thrombosis, impairment of positive vascular remodeling, and edge restenosis after geographic miss. Drug-coated balloons (DCB) deliver an antiproliferative agent to the vessel wall without leaving a permanent implant, and may be particularly attractive in long, fi...